PDS Biotechnology
PDSB
PDSB
52 hedge funds and large institutions have $36.2M invested in PDS Biotechnology in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $47.9M → $36.2M (-$11.7M)
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
52
Holding in Top 10
–
Calls
$2.94M
Puts
$710K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$629K | |
| 3 | +$489K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$338K |
| 5 |
D.E. Shaw & Co
New York
|
+$331K |
Top Sellers
| 1 | -$993K | |
| 2 | -$743K | |
| 3 | -$609K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$524K |
| 5 |
Two Sigma Investments
New York
|
-$363K |